ASPP2 suppresses squamous cell carcinoma via RelA/p65-mediated repression of p63.
Squamous cell carcinoma (SCC) is highly malignant and refractory to therapy. The majority of existing mouse SCC models involve multiple gene mutations. Very few mouse models of spontaneous SCC have been generated by a single gene deletion. Here we report a haploinsufficient SCC mouse model in which...
Main Authors: | Tordella, L, Koch, S, Salter, V, Pagotto, A, Doondeea, J, Feller, S, Ratnayaka, I, Zhong, S, Goldin, R, Lozano, G, McKeon, F, Tavassoli, M, Fritzsche, F, Huber, G, Rössle, M, Moch, H, Lu, X |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2013
|
Similar Items
-
Inhibitor of apoptosis-stimulating protein of p53 (iASPP) prevents senescence and is required for epithelial stratification.
by: Notari, M, et al.
Published: (2011) -
Investigation of the role of ASPP2 in tumourigenesis
by: Tordella, L
Published: (2012) -
ASPP2 is a haploinsufficient tumor suppressor that cooperates with p53 to suppress tumor growth.
by: Vives, V, et al.
Published: (2006) -
NF-κB repression by PIAS3 mediated RelA SUMOylation.
by: Yuangang Liu, et al.
Published: (2012-01-01) -
Identification of genes responsible for RelA-dependent proliferation arrest in human mammary epithelial cells conditionally expressing RelA
by: Bose S. Kochupurakkal, et al.
Published: (2016-03-01)